Galdu-irabazien kontua
DXC TECHNOLOGY CO
DXC
Errendimenduaren laburpena
Egin klik taulako edozein lerrotan grafikoan gehitzeko
milioika USDtan
| Neurria | Mar 31, 2025 2024 FY | Mar 31, 2024 2023 FY | Mar 31, 2023 2022 FY | Mar 31, 2022 2021 FY | Mar 31, 2021 2020 FY | Mar 31, 2020 2019 FY | Mar 31, 2019 2018 FY | Mar 31, 2018 2017 FY |
|---|---|---|---|---|---|---|---|---|
|
Diru-sarrerak
|
12,871.00 | 214.00 | 135.00 | 65.00 | 98.00 | 165.00 | 141.00 | 89.00 |
|
Diru-sarreren kostua
|
- | 298.00 | 199.00 | 209.00 | 414.00 | 386.00 | 324.00 | 380.00 |
|
Irabazi gordina
|
12,871.00 | -84.00 | -64.00 | -144.00 | -316.00 | -221.00 | -183.00 | -291.00 |
|
Ustiapen-gastuak
|
1,348.00 | 1,244.00 | 1,375.00 | 1,408.00 | 2,066.00 | 2,050.00 | 19,238.00 | 22,885.00 |
|
Ikerketa eta garapena
|
- | - | - | - | - | - | - | - |
|
Salmentak, orokorrak eta administratiboak
|
1,348.00 | 1,244.00 | 1,375.00 | 1,408.00 | 2,066.00 | 2,050.00 | 2,032.00 | 2,010.00 |
|
Beste ustiapen-gastu batzuk
|
- | - | - | - | - | - | - | - |
|
Ustiapen-irabaziak
|
11,523.00 | -1,328.00 | -1,439.00 | -1,552.00 | -2,382.00 | -2,271.00 | -19,421.00 | -23,176.00 |
|
Ez-ustiapeneko diru-sarrerak
|
10,893.00 | -1,437.00 | -554.00 | -2,693.00 | -3,036.00 | 2,957.00 | -20,936.00 | -24,847.00 |
|
Interesen diru-sarrerak
|
199.00 | 214.00 | 135.00 | 65.00 | 98.00 | 165.00 | 141.00 | 89.00 |
|
Interesen gastuak
|
265.00 | 298.00 | 200.00 | 204.00 | 361.00 | 383.00 | 334.00 | 335.00 |
|
Beste ez-ustiapeneko diru-sarrerak/gastuak
|
- | - | - | - | - | - | - | - |
|
Zerga aurreko irabazia
|
630.00 | 109.00 | -885.00 | 1,141.00 | 654.00 | -5,228.00 | 1,515.00 | 1,671.00 |
|
Zerga-gastua
|
241.00 | 18.00 | -317.00 | 423.00 | 803.00 | 141.00 | 258.00 | -80.00 |
|
Partaidetza ez-kontrolatzailea
|
7.00 | -5.00 | 2.00 | 18.00 | 3.00 | 11.00 | 5.00 | 31.00 |
|
Irabazi garbia
|
389.00 | 91.00 | -568.00 | 718.00 | -149.00 | -5,369.00 | 1,257.00 | 1,751.00 |
Informazio osagarria
Akzioko datuak, eratorritakoak eta bestelakoak — ez dira galdu-irabazien kontuaren parte
milioika USDtan, bestela adierazi ezean
| Neurria | Mar 31, 2025 2024 FY | Mar 31, 2024 2023 FY | Mar 31, 2023 2022 FY | Mar 31, 2022 2021 FY | Mar 31, 2021 2020 FY | Mar 31, 2020 2019 FY | Mar 31, 2019 2018 FY | Mar 31, 2018 2017 FY |
|---|---|---|---|---|---|---|---|---|
|
Amortizazioa eta balio-galera
|
- | - | - | - | - | - | - | - |
|
EBITDA
|
12,810.00 | 76.00 | 80.00 | 165.00 | -412.00 | -329.00 | -17,453.00 | -21,212.00 |
|
Akzioko irabazia (oinarrizkoa)
|
2.15 | 0.46 | -2.48 | 2.87 | -0.59 | -20.76 | 4.53 | 6.15 |
|
EPS diluitua
|
2.10 | 0.46 | -2.48 | 2.81 | -0.59 | -20.76 | 4.47 | 6.04 |
|
Akzioen batez besteko haztatua
|
180.68 | 195.80 | 228.99 | 250.02 | 254.14 | 258.57 | 277.54 | 284.93 |
|
Akzioen batez besteko haztatu diluitua
|
184.92 | 198.78 | 228.99 | 255.21 | 254.14 | 258.57 | 281.43 | 289.77 |
|
Irabazi globala
|
359.00 | 133.00 | -957.00 | 635.00 | 152.00 | -5,728.00 | 955.00 | 1,971.00 |